Efficacy and Safety of FEIBA Prophylaxis Evaluation in Young Patients With Haemophilia and High Titer Inhibitor

被引：0
|
作者：
Karimi, M. [1 ]
Tavoosi, H. [1 ]
Haghpanah, S. [1 ]
Ardeshiri, R. [1 ]
Zarei, T. [1 ]
机构：
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
来源：
HAEMOPHILIA | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP049
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF PROPHYLAXIS WITH AN ANTI-INHIBITOR COMPLEX CONCENTRATE IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS: RESULTS FROM PRO-FEIBA STUDY
    Gringeri, A.
    Leissinger, C.
    Cortesi, P. A.
    Cristiani, M.
    Fusco, F.
    Mantovani, L. G.
    VALUE IN HEALTH, 2012, 15 (07) : A511 - A512
  • [22] Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series
    Ettingshausen, C. Escuriola
    Kreuz, W.
    HAEMOPHILIA, 2010, 16 (01) : 90 - 100
  • [23] Assessing the efficacy and safety of FEIBA in the treatment of FX deficient patients
    Dilek, I.
    Oner, A.
    Gursel, T.
    Buyukavci, M.
    Salcioglu, Z.
    Ozatli, D.
    HAEMOPHILIA, 2008, 14 : 107 - 107
  • [24] Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis
    Daffunchio, Carla
    Galatro, Gustavo
    Rossi, Martin
    Landro, Maria
    Andreu, Mauro
    Neme, Daniela
    Caviglia, Horacio
    HAEMOPHILIA, 2021, 27 (04) : 641 - 647
  • [25] Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan
    Shen, Ming-Ching
    Chou, Sheng-Chieh
    Chiou, Shyh-Shin
    Lin, Pei-Chin
    Chen, Yeu-Chin
    Lin, Hsuan-Yu
    Lee, Yang-Cheng
    Huang, Cih-En
    Weng, Te-Fu
    Huang, Ting-Huan
    Chung, Chih-Yuan
    Chen, Jiann-Shiuh
    Chen, Shu-Huey
    Cheng, Shin-Nan
    Hsiao, Chih-Cheng
    Huang, Yen-Min
    Chen, Shih-Hsiang
    Yu, Yuan-Bin
    Lin, Shih-Chiang
    Lin, Ching-Yeh
    Peng, Ching-Tien
    Wang, Jiaan-Der
    HAEMOPHILIA, 2023, 29 (06) : 1499 - 1508
  • [26] A Turkish multicenter retrospective study on the efficacy and safety of FEIBA in patients with hemophilia and inhibitor and other rare bleeding disorders
    Zulfikar, B.
    Aydogan, G.
    Salcioglu, Z.
    Oner, A.
    Kavakli, K.
    Gursel, T.
    HAEMOPHILIA, 2008, 14 : 54 - 54
  • [27] Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B
    Mahlangu, Johnny
    Levy, Howard
    Lee, Martin
    Del Greco, Frank
    HAEMOPHILIA, 2021, 27 (04) : 574 - 580
  • [28] Effectiveness of Radioisotype Synoviectomy in Haemophilia Patients With High Titer Inhibitors
    Aytac, S.
    Bajin, I. Yaman
    Altan, I.
    Tuncel, M.
    Caglar, O.
    Cetin, M.
    Atilla, B.
    HAEMOPHILIA, 2017, 23 : 129 - 130
  • [29] Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey
    Zulfikar, B.
    Aydogan, G.
    Salcioglu, Z.
    Oner, A. F.
    Kavakli, K.
    Gursel, T.
    Zulfikar, H.
    HAEMOPHILIA, 2012, 18 (03) : 383 - 391
  • [30] The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
    Gringeri, A.
    Antmen, B.
    Berntorp, E.
    Biasioli, C.
    Carpenter, S.
    Kavakli, K.
    Lassila, R.
    Morfini, M.
    Negrier, C.
    Rocino, A.
    Schramm, W.
    Serban, M.
    Uscatescu, M. V.
    Windyga, J.
    Zulfikar, B.
    Leissinger, C.
    HAEMOPHILIA, 2011, 17 (02) : 363 - 363
12345